CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis
USA - NASDAQ:CCRN - US2274831047 - Common Stock
11.5 USD
-0.24 (-2.04%)
We assign a fundamental rating of 5 out of 10 to CCRN. CCRN was compared to 100 industry peers in the Health Care Providers & Services industry. CCRN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CCRN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
CCRN had positive earnings in the past year.
In the past year CCRN had a positive cash flow from operations.
In multiple years CCRN reported negative net income over the last 5 years.
CCRN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
CCRN has a Return On Assets (-1.51%) which is in line with its industry peers.
CCRN has a Return On Equity of -2.02%. This is comparable to the rest of the industry: CCRN outperforms 52.00% of its industry peers.
CCRN has a Return On Invested Capital of 1.44%. This is comparable to the rest of the industry: CCRN outperforms 41.00% of its industry peers.
CCRN had an Average Return On Invested Capital over the past 3 years of 15.05%. This is significantly above the industry average of 9.40%.
The last Return On Invested Capital (1.44%) for CCRN is well below the 3 year average (15.05%), which needs to be investigated, but indicates that CCRN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.51% | ||
| ROE | -2.02% | ||
| ROIC | 1.44% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
CCRN's Operating Margin of 0.78% is in line compared to the rest of the industry. CCRN outperforms 41.00% of its industry peers.
In the last couple of years the Operating Margin of CCRN has declined.
CCRN's Gross Margin of 20.19% is in line compared to the rest of the industry. CCRN outperforms 42.00% of its industry peers.
In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.78% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCRN is still creating some value.
CCRN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CCRN has been reduced compared to 5 years ago.
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
CCRN has an Altman-Z score of 4.83. This indicates that CCRN is financially healthy and has little risk of bankruptcy at the moment.
CCRN has a better Altman-Z score (4.83) than 82.00% of its industry peers.
There is no outstanding debt for CCRN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.83 |
ROIC/WACC0.16
WACC9.05%
2.3 Liquidity
CCRN has a Current Ratio of 3.21. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CCRN (3.21) is better than 86.00% of its industry peers.
CCRN has a Quick Ratio of 3.21. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
CCRN has a better Quick ratio (3.21) than 87.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.21 | ||
| Quick Ratio | 3.21 |
3. Growth
3.1 Past
CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.35%.
The Earnings Per Share has been growing by 24.57% on average over the past years. This is a very strong growth
Looking at the last year, CCRN shows a very negative growth in Revenue. The Revenue has decreased by -24.30% in the last year.
The Revenue has been growing by 10.33% on average over the past years. This is quite good.
EPS 1Y (TTM)-78.35%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-110%
Revenue 1Y (TTM)-24.3%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-19.34%
3.2 Future
Based on estimates for the next years, CCRN will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.16% on average per year.
CCRN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.63% yearly.
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 54.76, the valuation of CCRN can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as CCRN.
The average S&P500 Price/Earnings ratio is at 25.46. CCRN is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 43.78, which means the current valuation is very expensive for CCRN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CCRN is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of CCRN to the average of the S&P500 Index (35.39), we can say CCRN is valued slightly more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.76 | ||
| Fwd PE | 43.78 |
4.2 Price Multiples
67.00% of the companies in the same industry are more expensive than CCRN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, CCRN is valued cheaply inside the industry as 82.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.05 | ||
| EV/EBITDA | 11.21 |
4.3 Compensation for Growth
CCRN's earnings are expected to decrease with -16.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.23
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:CCRN (11/19/2025, 2:57:39 PM)
11.5
-0.24 (-2.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.83%
Inst Owner Change-0.49%
Ins Owners5.37%
Ins Owner Change-0.64%
Market Cap376.74M
Revenue(TTM)1.19B
Net Income(TTM)-8.35M
Analysts52.31
Price Target18.44 (60.35%)
Short Float %8.05%
Short Ratio6.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-56.4%
Min EPS beat(2)-118.38%
Max EPS beat(2)5.59%
EPS beat(4)2
Avg EPS beat(4)-39.17%
Min EPS beat(4)-118.38%
Max EPS beat(4)22.23%
EPS beat(8)4
Avg EPS beat(8)-22%
EPS beat(12)8
Avg EPS beat(12)-10.41%
EPS beat(16)12
Avg EPS beat(16)-0.77%
Revenue beat(2)0
Avg Revenue beat(2)-6.65%
Min Revenue beat(2)-7.46%
Max Revenue beat(2)-5.84%
Revenue beat(4)0
Avg Revenue beat(4)-3.61%
Min Revenue beat(4)-7.46%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-2.19%
Revenue beat(12)4
Avg Revenue beat(12)-0.89%
Revenue beat(16)7
Avg Revenue beat(16)0.6%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 54.76 | ||
| Fwd PE | 43.78 | ||
| P/S | 0.32 | ||
| P/FCF | 11.05 | ||
| P/OCF | 9.06 | ||
| P/B | 0.91 | ||
| P/tB | 1.57 | ||
| EV/EBITDA | 11.21 |
EPS(TTM)0.21
EY1.83%
EPS(NY)0.26
Fwd EY2.28%
FCF(TTM)1.04
FCFY9.05%
OCF(TTM)1.27
OCFY11.04%
SpS36.4
BVpS12.58
TBVpS7.31
PEG (NY)N/A
PEG (5Y)2.23
Graham Number7.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.51% | ||
| ROE | -2.02% | ||
| ROCE | 2.04% | ||
| ROIC | 1.44% | ||
| ROICexc | 1.75% | ||
| ROICexgc | 3.24% | ||
| OM | 0.78% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 2.86% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 42.39% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.74% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.21 | ||
| Quick Ratio | 3.21 | ||
| Altman-Z | 4.83 |
F-Score5
WACC9.05%
ROIC/WACC0.16
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.35%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-110%
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.3%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-19.34%
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
EBIT growth 1Y-69.02%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year540.8%
EBIT Next 3Y89.71%
EBIT Next 5YN/A
FCF growth 1Y-88.57%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-86.63%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
Can you provide the valuation status for CROSS COUNTRY HEALTHCARE INC?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
What is the financial health of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
The financial health rating of CROSS COUNTRY HEALTHCARE INC (CCRN) is 10 / 10.